SP 50/500 MG TABLET

Product Description

Product Name: SP 50/500 MG TABLETComposition: Sitagliptin 50mg + Metformin 500mgProduct Description for Trade India & B2B Platforms: SP 50/500 MG TABLET is a clinically proven combination of Sitagliptin 50mg and Metformin 500mg, formulated to manage Type 2 Diabetes Mellitus effectively. This dual-action oral antidiabetic helps improve glycemic control by enhancing insulin sensitivity and stimulating insulin secretion. Widely trusted by healthcare professionals, SP 50/500 MG is ideal for pharmaceutical wholesalers, retailers, and bulk buyers looking to stock a high-demand diabetes care solution.Key Benefits: Complementary Mechanism of Action: Sitagliptin (DPP-4 inhibitor) increases insulin release, while Metformin (biguanide) reduces hepatic glucose production. Effective HbA1c Reduction: Enhances long-term blood sugar management. Well-Tolerated Dosage: 500mg Metformin dose minimizes GI discomfort while maintaining efficacy. Convenient Oral Therapy: Suitable for once or twice-daily dosing with meals. Usage/Application: Used in adults with Type 2 Diabetes when monotherapy fails to provide adequate glycemic control. Often prescribed as a first-line combination therapy. To be administered under the guidance of a qualified healthcare professional. Why Choose SP 50/500 MG: Balanced formulation for beginner and maintenance diabetes therapy. Manufactured in WHO-GMP certified facilities with strict quality standards. Available in bulk packs with private labeling options for distributors. Competitive pricing and high demand across diabetic care segments.